| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $10,326,785 ) |
| | 2023 | 2023 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA247550 | Characterizing and Targeting the Novel IL-15- AKT-XBP1s Pathway in NK Cells | 000 | 4 | NIH | 11/8/2022 | $401,118 |
| | 2023 | 2023 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA236399 | The role and mechanism of METTL3/METTL14-mediated RNA modification in the pathogenesis and drug-resistance of AML | 000 | 5 | NIH | 1/26/2023 | $450,915 |
| | 2023 | 2023 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R37CA233691 | Combinational targeting the feed forward epigenetic circuitry in mixed lineage leukemia | 000 | 5 | NIH | 11/24/2022 | $356,164 |
| | 2023 | 2023 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA233922 | Targeting p38 gamma signaling to advance Cutaneous T Cell Lymphoma Therapy | 000 | 5 | NIH | 11/29/2022 | $622,666 |
| | 2023 | 2023 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R21CA277660 | Using Senolytics to Improve Physical Function in Older Breast Cancer Survivors | 000 | 1 | NIH | 12/22/2022 | $205,700 |
| | 2023 | 2023 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01NS106170 | Overcoming Barriers of Virotherapy by Next-Generation oHSV Expressing E-Cadherin | 000 | 5 | NIH | 12/9/2022 | $337,421 |
| | 2023 | 2023 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R21CA267570 | Targeting MUC16 transactivation for ovarian cancer treatment | 000 | 2 | NIH | 12/23/2022 | $222,156 |
| | 2023 | 2023 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01GM117923 | Structural dynamics underlying GPCR-G protein selectivity | 000 | 7 | NIH | 1/10/2023 | $316,800 |
| | 2023 | 2023 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R21CA256593 | Utilizing Hybrid Antigen-Presenting Neutrophils to Prime WT1-Specific Immune Responses as Therapy for Acute Leukemia | 000 | 2 | NIH | 11/10/2022 | $185,131 |
| | 2023 | 2023 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA258981 | The Role of miR-142 in the Transformation of Clonal Hematopoietic Disorders into AML | 000 | 2 | NIH | 12/22/2022 | $488,601 |
| | 2023 | 2023 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA258778 | Targeting tumor-associated macrophages for triple-negative breast cancer treatment | 000 | 2 | NIH | 11/18/2022 | $467,633 |
| | 2023 | 2023 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA266665 | Engineered anti-PSCA antibodies for immunoPET and targeted therapy of pancreatic cancer | 000 | 2 | NIH | 12/23/2022 | $656,535 |
| | 2023 | 2023 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01DK102233 | Targeting an atypical signaling hub to restore and protect whole body glucose homeostasis | 000 | 7 | NIH | 11/28/2022 | $396,000 |
| | 2023 | 2023 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | OT3HL152932 | CureSC Manufacturing Resource Platform | 000 | 1 | NIH | 1/5/2023 | $473,533 |
| | 2023 | 2023 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA241845 | Validation of epigenomic biomarkers for thyroid cancer diagnostics | 000 | 2 | NIH | 11/18/2022 | $756,670 |
| | 2023 | 2023 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01DK102233 | Targeting an atypical signaling hub to restore and protect whole body glucose homeostasis | 001 | 7 | NIH | 1/9/2023 | $44,000 |
| | 2023 | 2023 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01AI151013 | KSHV Subunit Vaccine Candidates to Elicit Potent Humoral Immune Reponses against KSHV Infection | 000 | 3 | NIH | 1/24/2023 | $851,034 |
| | 2023 | 2023 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01DK124116 | The function and underlying mechanism of TET1 in myelodysplastic syndromes | 000 | 4 | NIH | 1/18/2023 | $548,659 |
| | 2023 | 2023 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA243386 | Targeting FTO to treat acute myeloid leukemia | 000 | 4 | NIH | 11/16/2022 | $513,029 |
| | 2023 | 2023 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | P30CA033572 | Cancer Center Support Grant | 002 | 39 | NIH | 11/11/2022 | $1,134,816 |
| | 2023 | 2023 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01DK134652 | Role of trefoil factor family proteins in beta cell function. | 000 | 1 | NIH | 1/19/2023 | $565,036 |
| | 2023 | 2023 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA278050 | Mechanism and therapeutic opportunities of targeting the Tudor domain | 000 | 1 | NIH | 11/28/2022 | $510,917 |
| | 2023 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | P30CA033572 | Cancer Center Support Grant | 000 | 39 | NIH | 10/31/2022 | $0 |
| | 2023 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | DP5OD033424 | Biomarkers, mechanisms and modulation of oxidative stress associated risk factors in carcinogenesis | 000 | 1 | NIH | 10/13/2022 | $0 |
| | 2023 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | K12CA001727 | City of Hope Clinical Oncology Career Research Development Program | 000 | 28 | NIH | 1/23/2023 | $0 |
| | 2023 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | DP5OD033424 | Biomarkers, mechanisms and modulation of oxidative stress associated risk factors in carcinogenesis | 000 | 1 | NIH | 10/13/2022 | $0 |
| | 2023 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA266611 | Intracerebroventricular (ICV) Administration of CD19-Targeting Chimeric Antigen Receptor (CAR) T cells for Treatment of Primary Central Nervous System Lymphoma | 000 | 1 | NIH | 10/25/2022 | $0 |
| | 2023 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | K99AI159139 | Immune Evasion Mechanisms of KSHV Complement and Fc-Receptor Proteins | 000 | 1 | NIH | 11/9/2022 | $0 |
| | 2023 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | K76AG074918 | Targeting Senescence to Improve Frailty in Older Cancer Survivors | 000 | 1 | NIH | 10/19/2022 | $0 |
| | 2023 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R21CA273791 | Development of Family1st-An interactive web-based tool with evidence-based approaches to communicate hereditary cancer risk to at risk relatives and promote cascade testing. | 000 | 1 | NIH | 10/28/2022 | $0 |
| | 2023 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | P30CA033572 | Cancer Center Support Grant | 001 | 39 | NIH | 11/9/2022 | $0 |
| | 2023 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA263318 | Integration of epidemiology, pathology, immunology and outcomes in colorectal cancer | 000 | 1 | NIH | 12/23/2022 | $0 |
| | 2023 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | P20CA242619 | 1/2 Drug Development and Capacity Building: A UCR/CoH-CCC Partnership | 000 | 4 | NIH | 11/30/2022 | $0 |
| | 2023 | 2021 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01MH113407 | Transcriptional control, targeted modification, and excision of HIV in the brain | 000 | 5 | NIH | 1/25/2023 | $0 |
| | 2023 | 2020 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | P30CA033572 | Cancer Center Support Grant | 003 | 37 | NIH | 11/12/2022 | $0 |
| | 2023 | 2020 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R21CA223400 | scFvPD1-FLT3 CAR T Cells for the Treatment of Relapsed Acute Myeloid Leukemia | 000 | 2 | NIH | 12/6/2022 | $0 |
| | 2023 | 2020 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R21CA229967 | A Novel E3 Ubiquitin Ligase for CML Stem Cells | 000 | 2 | NIH | 10/17/2022 | $0 |
| | 2023 | 2019 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R21CA232275 | Precision Antibody-Based Therapy to Neutralize Epstein-Barr Virus-Associated PTLDs | 001 | 1 | NIH | 12/29/2022 | $0 |
| | 2023 | 2019 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R21CA232275 | Precision Antibody-Based Therapy to Neutralize Epstein-Barr Virus-Associated PTLDs | 000 | 2 | NIH | 12/29/2022 | $0 |
| | 2023 | 2019 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | U01ES026137 | Menopausal transition - a window of susceptibility for the promotion of breast cancer by environmental exposures | 000 | 5 | NIH | 11/23/2022 | $2 |
| | 2023 | 2019 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R25CA183723 | Geriatric Oncology: Educating nurses to improve quality care | 000 | 5 | NIH | 11/23/2022 | $8,155 |
| | 2023 | 2018 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | RF1AG061794 | ApoE2 in Alzheimer's disease: the neuroprotective effects and mechanisms | 000 | 1 | NIH | 12/8/2022 | $0 |
| | 2023 | 2018 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R21AI129471 | Identify ZIKV host factors with an improved CRISPR-based genome-wide knockout screen | 000 | 2 | NIH | 10/1/2022 | -$30,469 |
| | 2023 | 2018 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | U01DK085532 | Intestinal Stem Cell Consortium Coordinating Center | 000 | 10 | NIH | 10/11/2022 | -$105,404 |
| | 2023 | 2017 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01DK097837 | Physiologic Regulation of Hematopoiesis by Notch | 000 | 12 | NIH | 10/1/2022 | -$35,973 |
| | 2023 | 2017 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA172040 | Microenvironment-Leukemia Communication Through Lectins | 000 | 6 | NIH | 10/1/2022 | -$14,060 |
|
| Issue Date FY: 2022 ( Subtotal = $74,669,841 ) (Continued on the next page) |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA227602 | Exosomal Biomarkers for the Noninvasive Detection of Colorectal Cancer | 000 | 4 | NIH | 7/20/2022 | $508,313 |
| | 2022 | 2022 | BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | 1500 DUARTE RD | DUARTE | CA | 91010-3012 | LOS ANGELES | USA | R01CA242218 | Precision approaches to refining TP53-associated cancer risk | 000 | 4 | NIH | 8/30/2022 | $1,701,527 |
|
